Tumor burden of persistent disease in patients with differentiated thyroid cancer: correlation with postoperative risk-stratification and impact on outcome
Abstract Background In patients with differentiated thyroid cancer (DTC), tumor burden of persistent disease (PD) is a variable that could affect therapy efficiency. Our aim was to assess its correlation with the 2015 American Thyroid Association (ATA) risk-stratification system, and its impact on r...
Main Authors: | Renaud Ciappuccini, Natacha Heutte, Audrey Lasne-Cardon, Virginie Saguet-Rysanek, Camille Leroy, Véronique Le Hénaff, Dominique Vaur, Emmanuel Babin, Stéphane Bardet |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-08-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12885-020-07269-3 |
Similar Items
-
Thyroid 18F-fluorocholine uptake in patients with chronic autoimmune thyroiditis
by: Renaud Ciappuccini, et al.
Published: (2023-01-01) -
Course of Disease and Clinical Management of Patients with Poorly Differentiated Thyroid Carcinoma
by: Freba Grawe, et al.
Published: (2021-10-01) -
Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer
by: Petra Petranović Ovčariček, et al.
Published: (2023-08-01) -
Optimization of a dedicated protocol using a small-voxel PSF reconstruction for head-and-neck 18FDG PET/CT imaging in differentiated thyroid cancer
by: Renaud Ciappuccini, et al.
Published: (2018-12-01) -
Comparison of 1.1 GBq and 2.2 GBq Activities in Patients with Low-Risk Differentiated Thyroid Cancer Requiring Postoperative <sup>131</sup>I Administration: A Real Life Study
by: Alfredo Campennì, et al.
Published: (2023-04-01)